Related Experiment Video
Updated: Sep 20, 2025

03:46
Author Spotlight: Coproparasitoscopic Examination of Dog Stools for Control and Prevention of Zoonotic Parasite Diseases
Published on: December 15, 2023
2.9K
Reflections and future directions for continued development and refinement of guidelines for anthelmintic efficacy
Thomas Geurden1, Emily R Smith2, Jozef Vercruysse3
1Zoetis, Mercuriusstraat 20, 1930 Zaventem, Belgium.
Veterinary Parasitology
|June 6, 2022
Summary
This paper explains the World Association for the Advancement of Veterinary Parasitology (WAAVP) anthelmintic efficacy guidelines. It discusses background, technological advances, and future research for evaluating drug effectiveness in animals.
Area of Science:
- Veterinary Parasitology
- Drug Efficacy Evaluation
- Animal Health
Background:
- Complements the WAAVP general anthelmintic efficacy guideline.
- Provides insights into the rationale behind guideline recommendations.
- Discusses the evolution of anthelmintic efficacy testing.
Purpose of the Study:
- To offer background and context for the WAAVP general anthelmintic efficacy guideline.
- To explore emerging technologies relevant to anthelmintic efficacy evaluation.
- To identify areas for future research in parasitology and drug testing.
Main Methods:
- Reflective analysis of existing WAAVP guidelines.
- Discussion of recent technological advancements in efficacy testing.
- Identification of research gaps and future directions.
Main Results:
- Elucidation of the reasoning behind specific WAAVP guideline recommendations.
- Highlighting of novel technologies for potential inclusion in future guidelines.
- Proposal of research questions, including statistical methodologies for worm count analysis.
Conclusions:
- The paper provides essential context for understanding anthelmintic efficacy guidelines.
- Technological advancements may refine future efficacy evaluation protocols.
- Further research is needed to optimize statistical approaches and incorporate new methods.
Related Concept Videos
Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
Antimicrobial Effectiveness
179
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
179

